Tuesday, 25 Oct 2016

Today's Headlines

Seropositivity Increases Mortality Rates in Rheumatoid Arthritis

It has been long known that rheumatoid arthritis is associated with an increased mortality rate, especially in seropositive patients and those with extraarticular manifestations. With the advent of new RA associated autoantibodies, Ajegenova et al studied the effects of different autoantibodies on mortality and cause of mortality.

ACP Guidelines on the Diagnosis and Treatment of Low Back Pain

Low back pain (LBP) is the fifth most common reason for all physician visits in the United States and nearly 25% of all U.S. adults have had LBP in the  last 3 months and nearly 6% reported at least 1 episode of severe acute low back pain in the last 1-year.

Most Clinicians Do Not Order MRI/CT for Nonspecific Low Back Pain

Low back pain (LBP) is a highly prevalent public health problem. Not surprisingly, imaging of LBP is also an expensive and often overused diagnostic tool.  

Researchers from the Department of Veterans Affairs (VA) sought to define the problem and formulate recommendations to avoid ordering imaging tests for nonspecific LBP.

Early Intervention with Corticosteroids and IVIG is Crucial in Kawasaki Disease

The current JAMA Pediatrics issue has published a report showing that adjunctive corticosteroid therapy yielded significantly fewer coronary artery complications compared with intravenous immunoglobulin therapy alone, particularly among high-risk patients with Kawasaki disease.

RheumNow Week in Review – 21 October 2016

Dr. Cush Reviews Highlights from the past week on RheumNow.com. Register to receive free daily rheumatology news written by rheumatologists for rheumatologists. Download the podcast at iTunes.com.

Higher Lupus Disease Activity in First Year Postpartum

Most women with systemic lupus erythematosus (SLE) have no or little disease activity during pregnancy, but experience greater disease activity or overt flares during the first year postpartum, a Norwegian study has found.

Good News for Lupus Pregnancies

The Washington Post recently interviewed Dr. Eliza Chakavarty of the OMRF about the evolution in attitudes and outcomes of lupus women who wish to get pregnant.

Better understanding of the interplay between lupus activity and pregnancy outcomes, along with better medication, allows the discussion between hopeful patients and planful rheumatologists to be constructive ones. 

Everything will be alright in the end; and if it’s not alright, then it’s not yet the end. – Suni Kapoor (from the Best Exotic Marigold Hotel)

Yesterday's blog reviewed why you need a digital reboot.

This is written as a check-up to your digital self and a wake-up call to those of you who are disconnected lazily or willfully. This is written for the journal-subscribing, big textbook toting physicians whose primary education is acquired at the medical library, weekly medical conferences or grandiose annual conventions. Before you bail out on this blog, you should recognize the consequences of not being digital.
A recent article published by the American Academy of Ophthalmology presented new recommendations for screening of patients being managed with hydroxychloroquine that changed the previous monitoring paradigm. More importantly, it has repositioned hydroxychloroquine from one of the safest medications that rheumatologists use to a drug that can have potentially significant ocular morbidity (if used in doses greater than 5 mg per kilogram and or for prolonged periods of time).

Just yesterday I saw an Ank-Spond, 2 RA, 2 hand OAs and a teenager with lupus.

Travel can be challenging for arthritis patients. Here are some useful tips to travel smoothly and pain free.

Rheumatologists in Georgia and across the country are under extreme pressure to care for our patients. The Georgia Society of Rheumatology exists to stimulate interest and increase knowledge of arthritis and rheumatic diseases among physicians, allied health professionals, and lay advocates. Following are highlights of GRS issues and activities.